Aims There are few studies of the use of intra-aortic balloon pump (IABP) treatment as a bridge to heart transplantation (HTx). This is the first study to compare long-term clinical and haemodynamic ...
WAYNE, N.J., Maquet Getinge Group announced today the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps ...
MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, ...
Despite a lack of evidence, circulatory support with intraaortic balloon counterpulation (IABP) has a class 1 recommendation in the guidelines and is often used in patients in cardiogenic shock ...
The results of the Intraaortic Balloon Pump in Cardiogenic Shock (IABP-SHOCK) II trial, presented at the 2012 European Society of Cardiology Congress and published in the New England Journal of ...
"Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents: The Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting... Receive the the latest ...
Please provide your email address to receive an email when new articles are posted on . Infarct size as measured by MRI does not reduce when intra-aortic balloon pump counterpulsation is used before ...
Please provide your email address to receive an email when new articles are posted on . A routine strategy of intra-aortic balloon counterpulsation before percutaneous coronary intervention did not ...
This study demonstrates that IABP is a valuable tool as a bridge to HTx in patients with end-stage heart failure. Kaplan–Meier analysis revealed no significant difference in post-HTx survival between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results